secwatch.observer — SEC 8-K summary
======================================

Issuer:     Astrana Health, Inc. (ASTH)
CIK:        0001083446
Form:       8-K
Filed at:   2026-08-06T20:11:13+00:00
Accession:  0001104659-26-092003
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Astrana Health Q2 revenue $972.5M (+49% YoY); raises 2026 adjusted EBITDA guidance
--------------------------------------------------------------------------------

- Q2 revenue $972.5M (+49% YoY); net income attributable $19.7M (+109%); adjusted EBITDA $68.9M (+43%).
- Adjusted diluted EPS $0.80 (+45% YoY); six-month adjusted EPS $1.54 (+59%).
- Six-month free cash flow $92.9M; operating cash flow $100.8M.
- Management raises 2026 adjusted EBITDA guidance citing strong first-half outperformance.
- Care Partners revenue $932.8M (+48% YoY) drives top-line growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1083446/000110465926092003/0001104659-26-092003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1083446/000110465926092003/tm2622348d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-092003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer